Status:
COMPLETED
Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer
Lead Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Conditions:
Non Small Cell Lung Cancer (Squamous or Non Squamous)
Eligibility:
All Genders
70-89 years
Phase:
PHASE3
Brief Summary
For elderly patient, the treatment of Non Small Cell Lung Cancer was based on monotherapy but IFCT-0501 trial begun in 2006, demonstrated that a bitherapy (carboplatin and paclitaxel) is better than m...
Eligibility Criteria
Inclusion
- Histologically or cytologically documented Non Small Cell Lung Cancer non resectable or non irradiable stage III or stage IV
- EGFR wild type or non feasible EGFR
- 90 \>Age ≥ 70
- ECOG Performance status : 0, 1 or 2
- Mini-Mental Test Status (MMS) \> 23
Exclusion
- Mixed non-small cell and small cell tumors
- Patients with EGFR mutated tumor
- Patient with EML4-ALK translocation
- Evolutive or symptomatic metastasis of central nervous system
- Superior vena cava syndrome
- Calcemia \> 2,70 mmol/L
Key Trial Info
Start Date :
May 16 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
632 Patients enrolled
Trial Details
Trial ID
NCT01850303
Start Date
May 16 2013
End Date
January 31 2020
Last Update
March 14 2023
Active Locations (78)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbeville - CH
Abbeville, France, 80142
2
Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France
3
Amiens - CHU
Amiens, France
4
Clinique de l'Europe
Amiens, France